Investments
12Partners & Customers
10About Straumann
Straumann provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implant systems, biomaterials, CADCAM prosthetics, digital equipment, software, clear aligner systems, and various materials for dental applications. The company was founded in 1954 and is based in Basel Schweiz, Switzerland.

Want to inform investors similar to Straumann about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Straumann News
Sep 22, 2023
| Straumann Holding, Geistlich Pharma, Danaher News Provided By Share This Article Dental Biomaterial Stay up to date with Dental Biomaterial Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. HTF MI integrates History, Trends, and Forecasts to identify the highest value opportunities, cope with the most critical business challenges and transform the businesses.” — Criag Francis PUNE, MAHARASHTRA, INDIA, September 22, 2023/ EINPresswire.com / -- HTF Market Intelligence published a new research document of 150+pages on “ Dental Biomaterial Market Insights, to 2028" with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Dental Biomaterial market was mainly driven by the increasing R&D spending by leading and emerging player, however latest scenario and economic slowdown have changed complete market dynamics. Some of the key players profiled in the study are Straumann Holding AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (United States), Danaher Corporation (United States), Dentsply Sirona, Inc. (United States), 3M Company (United States), Royal DSM (Netherlands), Carpenter Technology Corporation (United States), Kuraray Co., Ltd. (Japan), Medtronic PLC (Ireland), Henry Schein, Inc. (United States), Mitsui Chemicals, Inc. (Japan), Victrex PLC (United Kingdom), GC Corporation (Japan), Others. According to HTF Market Intelligence, the Global Dental Biomaterial market to witness a CAGR of 7.3% during forecast period of 2023-2028. Global Dental Biomaterial Market Breakdown by Application (Orthodontics, Implantology, Prosthodontics, Others) by Type (Metallic, Ceramic, Polymeric, Others) by End User (Dental Hospitals and Clinics, Dental Laboratories, Dental Academies and Research Institutes, Dental Product Manufacturers, Others) and by Geography (North America, South America, Europe, Asia Pacific, MEA).The Dental Biomaterial market size is estimated to increase by USD 2.8 Billion at a CAGR of 7.3% from 2023 to 2028. The report includes historic market data from 2017 to 2022E. Currently, market value is pegged at USD 9.6 Billion. Get an Inside Scoop of Study, Request now for Sample Study @ https://www.htfmarketintelligence.com/sample-report/global-dental-biomaterial-market Definition: The Dental Biomaterial Market refers to the sector of the medical and healthcare industry that involves the research, development, production, and distribution of materials used in various dental procedures and treatments. Dental biomaterials are substances specifically designed for use within the oral cavity to restore, replace, or enhance dental structures such as teeth, gums, and supporting tissues. These biomaterials play a crucial role in modern dentistry, providing functional, aesthetic, and biocompatible solutions to a range of dental issues. Market Trends: Market Drivers: Market Opportunities: Market Restraints: The titled segments and sub-section of the market are illuminated below: The Study Explore the Product Types of Dental Biomaterial Market: Metallic, Ceramic, Polymeric, Others Key Applications/end-users of Dental Biomaterial Market: Orthodontics, Implantology, Prosthodontics, Others Book Latest Edition of Global Dental Biomaterial Market Study @ https://www.htfmarketintelligence.com/buy-now?format=1&report=5159 With this report you will learn: • Who the leading players are in Dental Biomaterial Market? • What you should look for in a Dental Biomaterial • What trends are driving the Market • About the changing market behaviour over time with strategic view point to examine competition Also included in the study are profiles of 15 Dental Biomaterial vendors, pricing charts, financial outlook, swot analysis, products specification & comparisons matrix with recommended steps for evaluating and determining latest product/service offering. List of players profiled in this report: Straumann Holding AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (United States), Danaher Corporation (United States), Dentsply Sirona, Inc. (United States), 3M Company (United States), Royal DSM (Netherlands), Carpenter Technology Corporation (United States), Kuraray Co., Ltd. (Japan), Medtronic PLC (Ireland), Henry Schein, Inc. (United States), Mitsui Chemicals, Inc. (Japan), Victrex PLC (United Kingdom), GC Corporation (Japan), Others Who should get most benefit from this report insights? • Anyone who are directly or indirectly involved in value chain cycle of this industry and needs to be up to speed on the key players and major trends in the market for Dental Biomaterial • Marketers and agencies doing their due diligence in selecting a Dental Biomaterial for large and enterprise level organizations • Analysts and vendors looking for current intelligence about this dynamic marketplace. • Competition who would like to benchmark and correlate themselves with market position and standings in current scenario. Make an enquiry to understand outline of study and further possible customization in offering @ https://www.htfmarketintelligence.com/enquiry-before-buy/global-dental-biomaterial-market Quick Snapshot and Extracts from TOC of Latest Edition Overview of Dental Biomaterial Market Dental Biomaterial Size (Sales Volume) Comparison by Type(2023-2028) Dental Biomaterial Size (Consumption) and Market Share Comparison by Application (2023-2028) Dental Biomaterial Size (Value) Comparison by Region (2023-2028) Dental Biomaterial Sales, Revenue and Growth Rate (2023-2028) Dental Biomaterial Competitive Situation and Current Scenario Analysis Strategic proposal for estimating sizing of core business segments Players/Suppliers High Performance Pigments Manufacturing Base Distribution, Sales Area, Product Type Analyse competitors, including all important parameters of Dental Biomaterial Dental Biomaterial Manufacturing Cost Analysis Latest innovative headway and supply chain pattern mapping of leading and merging industry players Get Detailed TOC and Overview of Report @ https://www.htfmarketintelligence.com/report/global-dental-biomaterial-market Thanks for reading this article, you can also make sectional purchase or opt-in for regional report by limiting the scope to only North America, ANZ, Europe or MENA Countries, Eastern Europe or European Union. Criag Francis
Straumann Investments
12 Investments
Straumann has made 12 investments. Their latest investment was in SmileCloud as part of their Corporate Minority on November 11, 2022.

Straumann Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
11/2/2022 | Corporate Minority | SmileCloud | Yes | 1 | ||
7/12/2022 | Corporate Minority - II | CareStack | No | 4 | ||
5/5/2022 | Corporate Minority | CareStack | Yes | 1 | ||
10/28/2021 | Corporate Minority | |||||
12/11/2018 | Corporate Minority |
Straumann Acquisitions
13 Acquisitions
Straumann acquired 13 companies. Their latest acquisition was Alliedstar on September 21, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
9/21/2023 | Acquired | 2 | ||||
5/25/2023 | Acquired | 3 | ||||
5/20/2022 | Series C | $87.91M | Acquired | 1 | ||
8/25/2021 | Seed / Angel | |||||
7/10/2020 |
Date | 9/21/2023 | 5/25/2023 | 5/20/2022 | 8/25/2021 | 7/10/2020 |
---|---|---|---|---|---|
Investment Stage | Series C | Seed / Angel | |||
Companies | |||||
Valuation | |||||
Total Funding | $87.91M | ||||
Note | Acquired | Acquired | Acquired | ||
Sources | 2 | 3 | 1 |
Straumann Partners & Customers
10 Partners and customers
Straumann has 10 strategic partners and customers. Straumann recently partnered with Sunbit on October 10, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
10/12/2022 | Vendor | United States | Straumann Group Names Sunbit for Consumer Finance The Straumann Group announced that it has chosen Sunbit as a preferred consumer financing tool for use in practices across the U.S. | 3 | |
9/20/2022 | Partner | United States | Ceramic Brackets And Transparent Aligners Are Expected To Gain Traction During The Forecast Period Ormco Corporation and Institut Straumann AG are well-known in the business due to their expanded distribution networks , stronger market penetration , and strategic alliances . | 1 | |
6/8/2022 | Partner | United States | Oral-B & Straumann Alliance : Partnering to Amplify the Importance of Prevention | 1 | |
1/1/2022 | Partner | ||||
9/8/2021 | Client |
Date | 10/12/2022 | 9/20/2022 | 6/8/2022 | 1/1/2022 | 9/8/2021 |
---|---|---|---|---|---|
Type | Vendor | Partner | Partner | Partner | Client |
Business Partner | |||||
Country | United States | United States | United States | ||
News Snippet | Straumann Group Names Sunbit for Consumer Finance The Straumann Group announced that it has chosen Sunbit as a preferred consumer financing tool for use in practices across the U.S. | Ceramic Brackets And Transparent Aligners Are Expected To Gain Traction During The Forecast Period Ormco Corporation and Institut Straumann AG are well-known in the business due to their expanded distribution networks , stronger market penetration , and strategic alliances . | Oral-B & Straumann Alliance : Partnering to Amplify the Importance of Prevention | ||
Sources | 3 | 1 | 1 |
Straumann Team
11 Team Members
Straumann has 11 team members, including current Chief Executive Officer, Guillaume Daniellot.
Name | Work History | Title | Status |
---|---|---|---|
Guillaume Daniellot | Chief Executive Officer | Current | |
Name | Guillaume Daniellot | ||||
---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer | ||||
Status | Current |
Compare Straumann to Competitors

Candid provides transformative oral health care. It offers a kit that highlights and monitors virtual check-ins regarding dental issues. It delivers a network of orthodontists that helps to design and implements a treatment plan. Its product includes teeth whitening kits, an enamel protection kit, and more. The company was formerly known as Briya. It was founded in 2017 and is based in New York, New York.
Twice is a developer of oral care products.

Dandy operates as a dental technology company. The company focuses on improving day-to-day services for dental professionals and patients alike. It offers Labs, a free digital platform for dentists that provides them with technology and tools to be more. It was founded in 2016 and is based in New York, New York.
3D Predict is a clear aligner manufacturer, leveraging artificial intelligence that predictably helps treat all cases of complexity. The company's Unique Deep CBCT Analysis allows the predictable and safe movement of teeth within the bone and avoids anatomically impossible movements, such as root collision.
Stabl is a post-operative rehabilitation platform. It uses live motion analysis on a laptop camera to facilitate daily rehabilitation sessions and provide data-driven insights. It was founded in 2020 and is based in Toronto, Canada.

Cagenix develops and researches new devices for dental implants. The company's main focus is on providing superstructures for multiple dental implants that is used to restore chewing function and aesthetics for patients.